Sai Life Sciences Limited (SAILIFE) — Offer Document | 7 August 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Monitoring Agency Report confirms full IPO proceeds utilization as per offer document for Q1 FY2026.
🔄 What Changed
Rs 371.11 million spent on issue expenses by June 30, 2026; Rs 30.05 million remains in cash equivalents.
🔮 What's Next
No future utilization plans or deadlines were specified in the report.
💡 Investor Takeaway
Investors can view this as validation that IPO funds were used strictly for disclosed purposes with no unapproved deviations.

Sai Life Sciences Limited disclosed its Monitoring Agency Report for the quarter ended June 30, 2026, confirming compliance with IPO utilization norms. The report verifies that proceeds of Rs 9,500 million were fully deployed as per the offer document, with no deviations in object costs or timelines. All Rs 9,500 million gross proceeds were allocated to repayment of borrowings (Rs 7,200 million), general corporate purposes (Rs 1,898.84 million), and issue expenses (Rs 401.16 million), of which Rs 371.11 million were spent by June 30, 2026, leaving Rs 30.05 million in cash equivalents. The Monitoring Agency, CRISIL Ratings Limited, affirmed no conflicts of interest and validated the accuracy of disclosures based on management certificates and peer-reviewed accounting reviews.

📄 View Original Announcement (PDF)

About Sai Life Sciences Limited (SAILIFE)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹30,970.41 Cr P/E: 85.0 ROE: 14.6% ROCE: 20.1%

View full SAILIFE stock details →

📡 Get AI alerts when SAILIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SAILIFE — Free

📊 More SAILIFE filings

See all SAILIFE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SAILIFE files new disclosures

Track SAILIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SAILIFE — Free

Free account · 2 AI queries/day